HER2-positive Colorectal Cancer
6 clinical trials · Condition
◉ Watch HER2-positive Colorectal Cancer
| Record | Firm | Date |
|---|---|---|
| A Safety and Activity Study of SBT6050 in Combination With Other HER2-directed Therapies for HER2-positive Cancers (NCT05091528) | Silverback Therapeutics | 2022-02-08 |
| A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors (NCT04278144) | Bolt Biotherapeutics, Inc. | 2020-02-24 |
Track HER2-positive Colorectal Cancer automatically
Every clearance here is in the API, with alerts when new ones post.